Tag: Trastuzumab emtansine

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Trastuzumab emtansine

AstraZeneca Gets CDSCO Panel Nod for Enhertu 100mg for additional indication of breast cancer

Added to Collection on: 2023-12-25 17:56:08

Tags for this article:

Antibody-drug conjugates
Orphan drugs
Immunology
Cancer treatments
Antineoplastic drugs
HER2
Trastuzumab deruxtecan
Trastuzumab
Trastuzumab emtansine
Breast cancer

Click the tags to see associated articles and topics

View Article Details
AstraZeneca Pharma gets CDSCO nod for Trastuzumab deruxtecan use for 2 more indications

Added to Collection on: 2024-03-29 16:17:37

Tags for this article:

Antibody-drug conjugates
Orphan drugs
Cancer treatments
Daiichi Sankyo
Trastuzumab deruxtecan
Immunology
Trastuzumab
HER2
Breast cancer
Drugs Controller General of India
Trastuzumab emtansine
Pertuzumab
ASTRAZENECA PHARMA INDIA

Click the tags to see associated articles and topics

View Article Details
FDA Approves Enhertu for All Types of HER2-Positive Tumors - Cancer Health

Added to Collection on: 2024-04-06 20:25:54

Tags for this article:

Antineoplastic drugs
Orphan drugs
Immunology
Antibody-drug conjugates
HER2
Trastuzumab
Antibody-drug conjugate
Non-small-cell lung cancer
Breast cancer
Trastuzumab emtansine
Pertuzumab

Click the tags to see associated articles and topics

View Article Details
Targeted therapy for advanced breast cancer

Added to Collection on: 2024-04-28 22:23:42

Tags for this article:

Antineoplastic drugs
Cancer treatments
Immunology
Trastuzumab
Antibody-drug conjugates
HER2
Pertuzumab
Trastuzumab emtansine
Chemotherapy
Tłı̨chǫ

Click the tags to see associated articles and topics

View Article Details
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation - Yahoo Finance

Added to Collection on: 2024-05-21 17:16:29

Tags for this article:

Cyclopentanes
Specialty drugs
Protein kinase inhibitors
Antineoplastic drugs
Amides
Trastuzumab emtansine
Inavolisib
Palbociclib
Fulvestrant
Breast cancer
Trastuzumab
Ribociclib

Click the tags to see associated articles and topics

View Article Details
Enhertu Delays Progression of HER2-Low and Ultralow Metastatic Breast Cancer

Added to Collection on: 2024-06-03 12:39:04

Tags for this article:

Breast cancer
Antineoplastic drugs
Antibody-drug conjugates
Immunology
Orphan drugs
Trastuzumab emtansine
Trastuzumab
Pertuzumab
Triple-negative breast cancer
Antibody-drug conjugate
Metastatic breast cancer
CDK inhibitor
T-DM1

Click the tags to see associated articles and topics

View Article Details
AstraZeneca disappointed by breast cancer drug trial results - MarketScreener

Added to Collection on: 2024-06-18 20:42:40

Tags for this article:

Breast cancer
Triple-negative breast cancer
HER2
AstraZeneca
Buparlisib
Trastuzumab emtansine
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results - Morningstar

Added to Collection on: 2024-06-18 15:07:31

Tags for this article:

Breast cancer
Triple-negative breast cancer
HER2
AstraZeneca
Buparlisib
Trastuzumab emtansine
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
Antibody Drug Conjugates Market to See Booming Growth 2024-2031 - openPR.com

Added to Collection on: 2024-08-12 13:34:38

Tags for this article:

Immunology
Antibody-drug conjugates
Antineoplastic drugs
Biotechnology
Monoclonal antibodies
Antibody-drug conjugate
ImmunoGen
Mertansine
Antibody
AbbVie
Trastuzumab emtansine
Targeted therapy

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Enhertu included in China's state insurance reimbursement - TradingView

Added to Collection on: 2024-11-28 20:39:31

Tags for this article:

Antibody-drug conjugates
Immunology
Orphan drugs
Breast cancer
AstraZeneca
Medical research
Antibody-drug conjugate
Trastuzumab deruxtecan
HER2
Daiichi Sankyo
Patritumab deruxtecan
Trastuzumab emtansine

Click the tags to see associated articles and topics

View Article Details